COVID-19 Diagnostic Testing Market: Insights, Competition and 2020-2025 Forecast

Prevail Drug Coated Balloon Catheter Launches in Europe

Prevail Drug coated balloon catheter is used during percutaneous coronary intervention procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease.

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

June 4, 2020

COVID-19 Diagnostic Testing Global Market is estimated to be valued at USD 44,481.8 million for the year 2020 owing to a rapid increase in the number of coronavirus cases across the globe which boosts the demand for COVID-19 diagnostic tests.

The COVID-19 diagnostic tests are critical in the management of the current pandemic for accurate diagnosis as well as to tackle the spread of the infection. Also, Global COVID-19 Diagnostic Testing market in terms of COVID-19 Tests is expected to reach the number of 329.17 million in the year 2020.

In March 2020, the Food and Drug Administration (FDA) gave Emergency Use Authorization (EUA) to the first POC test-Xpert Xpress test made by Cepheid-for COVID-19 analysis. Abbott and Chembio Diagnostics are among the dynamic market players working for the purpose of care commercial center. The WHO has encouraged healthcare organizations to focus on COVID-19 indicative testing in light of this emergency.

The companies are also adopting profitable strategic moves to gain a competitive edge in the market. For example, in May 2020, Quest Diagnostics announced its collaboration with Ortho Clinical Diagnostics aimed at the expansion of COVID-19 antibody testing across more than 20 laboratories of Quest throughout U.S. The company applied VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test of Ortho to ramp up the coronavirus testing in patients.

Among the Test Type segment in the COVID-19 Diagnostic Testing market (Molecular Tests, Serology Tests), Molecular Test type segment has been gaining popularity among other segments. Robust funding and speculations by public as well as private organizations are relied upon to impel molecular diagnostic organizations to create COVID-19 symptomatic products, in this way driving the market.

Based on End-User segment, Private or Commercial labs segment holds the major share in the COVID-19 diagnostic testing market followed by Public health labs and hospitals. Due to the growing number of COVID-19 cases across the globe, it has become imperative for the government of the various countries to involve a greater number of private or commercial firms in providing diagnostic testing in order to enhance the testing capacity to detect the virus.

Scope of the Report

  • The report analyses the COVID-19 Diagnostic Testing market by Value and by COVID-19 Tests.
  • The report analyses the COVID-19 Diagnostic Testing Market by Test Type (Molecular Tests, Serology Tests).
  • The report assesses the COVID-19 Diagnostic Testing market by End-User (Public Health Labs, Private or Commercial Labs, Others).
  • The Global COVID-19 Diagnostic Testing Market has been analysed by Region (Americas, Europe, Asia Pacific) and by Country (United States, Canada, Brazil, Germany, France, Italy, United Kingdom, Spain, Russia, China, Japan, India, South Korea, Singapore)
  • The major trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, COVID-19 vaccine development. The companies analysed in the report include Biomerieux, Roche Holding AG, Siemens Healthineers, Abbott Laboratories, Becton Dickinson, Thermo Fisher Scientific, Cepheid, BGI Genomics, Seegene, PerkinElmer.
  • The report presents the analysis of COVID-19 Diagnostic Testing market for the forecast period of 2020-2025.

Key Topics Covered

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. Global COVID-19 Diagnostic Testing Market: Product Outlook

4. Global COVID-19 Diagnostic Testing Market: Sizing and Forecast

4.1 Market Size, by Value, Year 2020-2025

4.2 Market Size, by COVID-19 Tests, Year 2020-2025

5. Global COVID-19 Diagnostic Testing Market Segmentation by Test Type

5.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: by Test Type

5.2 Molecular Tests-Market Size and Forecast (2020-2025)

5.3 Serology Tests-Market Size and Forecast (2020-2025)

6. Global COVID-19 Diagnostic Testing Market Segmentation by End-User

6.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: by End-User

6.2 Public Health Labs-Market Size and Forecast (2020-2025)

6.3 Private or Commercial Labs-Market Size and Forecast (2020-2025)

6.4 Others-Market Size and Forecast (2020-2025)

7. Global COVID-19 Diagnostic Testing Market: Regional Analysis

7.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: by Region, by Value

8. Americas COVID-19 Diagnostic Testing Market: Segmentation by Test Type, End-User (2020-2025)

9. Europe COVID-19 Diagnostic Testing Market: Segmentation by Test Type, End-User (2020-2025)

10. Asia Pacific COVID-19 Diagnostic Testing Market: Segmentation by Test Type, End-User (2020-2025)

11. Global COVID-19 Diagnostic Testing Market Dynamics

11.1 Global COVID-19 Diagnostic Testing Market Drivers

11.2 Global COVID-19 Diagnostic Testing Market Restraints

11.3 Global COVID-19 Diagnostic Testing Market Trends

12. COVID-19 Vaccine Development

12.1 Overview of Vaccine Development

12.2 Overview of the leading vaccine candidates

13. Competitive Landscape

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)

14.1 bioMerieux

14.2 Roche Holding AG

14.3 Siemens Healthineers

14.4 Abbott Laboratories

14.5 Becton Dickinson

14.6 Thermo Fisher Scientific

14.7 Cepheid

14.8 BGI Genomics

14.9 Seegene

14.10 PerkinElmer

For more information visit here.

spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.